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INTRODUCTION
Medicinal plants are the ingredients of many currently 
important pharmaceutical drugs with broad biological 
activity. There has been a growing interest in studying 
plant secondary metabolites as they represent a tremendous 
library of potentially useful leading compounds for new drug 
development. In fact, many modern drugs are compounds 
isolated from plants, which are used in the treatment of 
many diseases including cancer, e.g. taxol from yew tree, 
or vincristine from periwinkle. Pharmaceutical industry is 
still searching for new drugs with anticancer potency. Since 
there are no effective drugs to treat most cancers, it seems 
a good solution to produce the anti-leukemic drugs with 
natural origin. Some natural products are mostly composed 
of complex compounds, which act synergistically [5, 10]. 
Eleutherococcus is a genus of the Araliaceae family, 
which includes approximately 40 species native to North 
Russia and Asia. The plants from Eleutherococcus genus 
Cytotoxic activity of ethanolic extracts of Eleutherococcus species 
cultivated in Poland on HL60 leukemia cell line
Daniel Zaluski1*, Helena Danuta Smolarz2, Anna Bogucka-Kocka2
1 Chair and Department of Pharmacognosy, Jagiellonian University, Collegium Medicum, Medyczna 9, 30-568 Cracow, Poland 
2 Chair and Department of Pharmaceutical Botany, Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland
Corresponding author
* e-mail: daniel.zaluski@uj.edu.pl 
tel./fax: +48 12 742 37 02
have been used in medicine, especially in Chinese medicine 
for many years. The roots of Eleutherococcus senticosus 
have been traditionally used as a folk remedy for many 
diseases including diabetes, hypertension and cancer. The 
leaves are used as a tonic, as a functional beverage commer-
cially marketed for reducing liver damage and accelerating 
alcohol detoxicification.
There is an increasing interest in alternative or herbal 
medicine for the prevention and treatment of various ill-
nesses and an increasing number of scientific research is 
focusing on these species. As the Eleutherococcus species 
have wide pharmacological properties, there is a need to 
carry out research towards anti-leukemic properties. The 
abundance and variety of chemical compounds give a large 
hope for new drugs [10, 12-13]. 
The main chemical compounds present in these species 
are glycosides, known as eleutherosides. Eleutherosides are 
the derivatives of coumarins, lignans, sterols and triterpenic 
acids. A special attention is given to eleutherosides B, E 
and E1, the compounds, which according to some authors, 
play a dominant role in the treatment of many diseases. 
Our previous phytochemical investigations have shown that 
eleutehrosides B, E and E1 are present in all the investigated 
species cultivated in Poland [1]. 
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E. senticosus is the best-known species of all species 
belonging to Eleutherococcus genus. Its monograph 
can be found in several Pharmacopoeias; e.g. European, 
American or Polish. According to Pharmacopoeias the roots 
of E. senticosus should contain at least 0.08% of the sum 
of eleutheroside B and E. Apart from eleutherosides also 
polysaccharides, essential oil, eleutherans, phenolic acids 
and diketopiperazines have been found. The medicinal 
properties of E. senticosus are compared to Panax ginseng 
or Aralia mandshurica. This species is classified as 
adaptogenic plant, which can increase the ability of 
the organism to adapt to environmental factors and to 
avoid damage from such factors. It is worth noting, that 
the extracts from this species were used after nuclear 
explosion in Chernobyl in order to reduce the effects 
of radiation. E. senticosus is also used in the treat-
ment of bacterial and viral infections. In addition, it has 
been reported, that E. senticosus has antiinflammatory, 
immunostimulatory and immunomodulatory properties 
[1, 7-9, 19]. 
Apart from E. senticocus, the Chinese Traditional 
Medicine has also used E. gracilistylus, E. sessiliflorus 
and E. setchuensis. The extracts and isolated compounds 
have been shown to have various levels of activity such 
as antibacterial, antiinflammatory, anti-gout, anti-hepa-
titis, anti-hyperglycemic, anti-oxidant, anti-pyretic, cho-
leretic, radioprotectant, hemostatic, immunostimulatory 
and hypocholesterolemic effects. The bark from the roots 
of E. gracilistylus described in Chinese Pharmakopoeia as 
Cortex Acanthopanacis (Wujiapi) is used in the treatment 
of rheumatism. The products containing the root bark are 
recommended as ”therapeutic wine” [11-12, 16].
The anti-leukemic properties of Eleutherococcus species 
cultivated in Poland have not been researched yet. World 
literature reports mainly on one species, E. senticocus. 
Anti-leukemic activity of these species is unknown, in this 
case the main aim of studies was to establish these properties 
and to explain, whether they induce apoptosis or necrosis in 
HL60 leukemia cells. 
MATERIAL AND METHODS 
PLANT MATERIAL
The roots, spring and autumn leaves of E. senticosus 
(Rup. et Maxim.) E. setchuensis (Harms) Nakai, E. ses-
siliflorus (Rupr. et Maxim.) S. Y. Hu, E. gracilistylus 
(W. W. Smith) S. Y. Hu, E. henryi Oliv. and E. divaricatus 
(Siebold & Zucc.) S. Y. Hu were obtained from arbore-
tum in Rogów (Poland). The spring leaves were collected 
in June 2010, while the roots and autumn leaves in October 
2010. Voucher specimens were deposited at the Chair and 
Department of Pharmaceutical Botany, Medical University 
of Lublin, Poland, and was numbered as E01, E02, E03, 
E04, E05, E06, respectively. 
PREPARATION PLANT SAMPLES 
The air-dried and powdered roots and leaves (15 g) were 
soaked for 24 h in 150 mL of 75% ethanol, in a round-bot-
tomed flask. After that, the samples were sonicated in an ultra-
sonic bath (Polsonic, Warsaw, Poland) at room temperature 
for 15 min. The liquids were carefully filtered and the 
plant material was re-extracted for 15 min. with 100 mL 
of the same solvent. The filters, on which the samples were 
filtered, were sonicated afterwards, with 100 mL 75% 
ethanol. There was obtained 350 mL of each extract. The 
solvents were evaporated under reduced pressure at 45°C 
and subjected to lyophilisation. 
BIOASSAYS
Cell culture
Leukemic cells (HL60 cell line, ECACC, cat. no. 
980 701 06) were incubated at the concentration of 5×105 
cells/mL in 5% CO2 atmosphere for 24 h at 37°C. An RPMI 
1640 medium (Sigma, St. Luis, USA) , with 15% fetal 
bovine serum (Sigma), 2 mM L-glutamine and antibiotics 
[100 U/mL penicillin, 100 µM/mL streptomycin and 2.5 
µg/mL amphotericin B (Gibco, Carlsbad, USA) served as 
a growing medium. 
Cytotoxicity test-trypan blue assay
The in vitro cytotoxicity assay was carried out using 
trypan blue assay. The HL60 cell line in concentration 5×105 
cells/mL was treated with different concentrations of testing 
extracts and incubated for 24 h at 37°C in air atmosphere 
humidified by 5% CO2. At the end of this period, the medium 
was removed from each plate by aspiration. Next, the cells 
were washed with PBS and centrifuged at 800 rpm for 10 
min, and then PBS was removed by aspiration. Than 10 
μL suspension cells were incubated for 5 min with the 10 
μl 0.4% trypan blue solution (Sigma). The samples were 
analyzed using an Olympus BX41 light microscope. The 
cells were stimulated with the ethanol extracts from the roots 
and leaves dissolved in DMSO at the final concentration 2; 
25; 100; 300; 600 µg/mL of cell culture. The final concentra-
tion of DMSO in incubating mixture was 1%. Every assay 
was performed in triplicate.
Apoptotic test-Annexin V assay
The annexin-V-Fluos assay was used to estimate the 
number of cells in the stage of apoptosis. After 24h cell 
cultures were centrifuged at 800 rpm for 10 min. and 
the culture medium was removed. Than they were incu-
bated for 5 min in the buffer comprising 10 mM Hepes 
[N-(2-hydroxyethyl) piperazine-N’-(2-ethanesulfonic acid) 
hemisodium salt]/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM 
CaCl2, annexin V labeled with 0.65 µg/mL of FITC 
and propidium iodide at the concentration of 12 µg/mL. 
Thereafter, the samples were analyzed by an Olympus 
BX41 light and fluorescence microscope for the presence 
of: a) viable cells-annexin V negative, PI negative, 
b) earlyapoptotic cells – annexin V positive, PI negative, 
c) late apoptotic/secondary necrotic-annexin V positive, 
PI positive.
The number of apoptotic cells per sample was determined 
as the percentage of annexine V positive cells per sample. 
HL60 cell line without the extract was used as a positive 
control. Cell morphology was examined using a BX41 
Olympus fluorescence microscope. Data were processed 
according to the Multi Scan software.
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RESULTS 
On the basis of the obtained results, it was concluded 
that all the examined extracts show cytotoxic activity 
against leukemic cells. The IC50 values summarized up in 
Table 1 are differentiated, depending on the type of raw 
material. The IC50 value ranged between 49 and 522 µg/mL. 
The highest cytotoxicity effect was observed in the case of 
the extract from roots. The most active was the extract from 
the roots of E. divaricatus (IC50; 49 µg/mL).
Table 1. IC50 [µg/mL] of extracts from Eleutherococcus spp. 
Species Roots* Spring leaves* Autumn leaves*
E. senticosus 208 ± 0.005 312 ± 0.1 299 ± 0.004
E. divaricatus 49 ± 0.008 223 ± 0.005 270 ± 0.005
E. setchuensis 135 ± 0.06 522 ± 0.2 518 ± 0.3
E. sessiliflorus 128 ± 0.009 400 ± 0.07 325 ± 0.04
E. gracilistylus 206 ± 0.01 100 ± 0.003 100 ± 0.005
E. henryi 185 ± 0.007 116 ± 0.09 209 ± 0.08
* Results in terms of mean ± standard deviation
The obtained results show that IC50 values for the 
extracts from spring and autumn leaves are similar for the 
particular species. The lowest IC50 was obtained for the 
leaves of E. gracilistylus and E. henryi (100-209 µg/mL), 
the least active was the extract from the spring leaves of 
E. setchuensis (522 µg/mL). The percentage of living, apop-
totic and necrotic leukaemic cells after 24 h stimulation 
with extracts from roots at concentration IC50 is presented 
in Fig. 1.
Figure 1 presents that all the samples contribute to acti-
vation of apoptosis process in leukemia cells. The number 
of apoptotic cells ranged between 43% and 32%, necrotic 
cells between 17% and 9%. The most apoptotic cells were 
determined in E. divaricatus (43%) whereas the number 
of necrotic (toxic effect of the extracts) cells was the highest 
in E. gracilistylus (17%). The percentage of apoptotic cells 
in controls was lower than 5%. 
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Figure 1. Living, apoptotic and necrotic HL 60 cells (24 h 
culture) after stimulation with ethanolic extracts from the roots 
of Eleutherococcus spp. The concentration of the extracts equalled 
IC50
DISCUSSION
Eleutherococcus spp. has been a subject of many studies 
for many years. Its secondary compounds have shown to 
have a wide range of pharmacological activities. 
It is thought that eleutherosides are responsible for the 
medical activity of Eleutherococcus spp. Based on studies on 
the extracts and their ingredients, including eleutherosides, 
it appeared that they are very well absorbed in human intes-
tines and accumulated in plasma, heart, kidney and liver. 
Unfortunately, these species are native of eastern Asia and 
currently are cultivated only in European botanic gardens. 
The chemical analysis performed by the authors has shown 
that the investigated species contain eleutherosides B and E, 
whose content is higher than the requirements of pharma-
copoeia. Our earlier studies have shown that eleutherosides 
B, E and E1 are in all roots and fruits, but not in the leaves 
[1, 2, 17].
In the present study, HL-60 cell line was used as an in 
vitro model to examine the cytotoxic and apoptotic proper-
ties of the ethanolic extracts from the roots of spring and 
autumn leaves of the species belonging to Eleutherococcus 
genus cultivated in Poland. These species are cultivated at 
the botanical garden in Rogów, which lies in the Central 
Polish Lowlands region with geographic data such as 
51°49’N and 19°53’E. The vegetative period lasts for 212 
days and the average annual precipitation is 596 mm, of 
which 80% occurs during the vegetative period. The average 
annual air temperature is 7.2°C. The average, long-term tem-
perature is – 20.1°C, what classified the garden to the 6bth 
sub-climate (according to “USDA Frost Hardiness Zones”) 
and to the second zone according to the Kórnik category. 
These plants are grown on the acidic, luvic and sand soils 
[14]. 
Leukemia is one of the most frequently occurring diseases 
among young people to 30 years of age. For many years, 
the increase in the incidence of leukemia has been observed, 
especially in children and young people. Because of growing 
resistance to drugs, the treatment of leukemia is very dif-
ficult. New drugs with antileukemic or strengthening body 
properties are still being searched for. One of the most 
intensely studied areas of research has been the investiga-
tion of plants with anticancer action. 
World scientific literature refers mainly to the research 
on one species, namely E. senticosus. The earlier studies 
performed by Hacker and Medon revealed cytotoxic effect 
of E. senticosus water extract against L1210 leukemia cells 
with ED50 value of 75 µg/mL [4]. Other studies performed 
by Yoon et al. [15] have shown anti-metastatic activity of 
a water extract of E. senticosus. The extract inhibited lung 
metastasis of colon 26-M3.1. An in vitro analysis showed 
that the extract affects the growth of colon 26-M3.1 cells at 
the concentration higher than 1000 µg/mL [15]. Additional 
studies performed by the above authors have shown that the 
glycoprotein fraction is responsible for the anti-metastatic 
activity of the extract . Based on the obtained results it 
appeared that the glycoproteins fraction showed higher anti-
metastatic activity and higher stimulation of the proliferation 
of splenocytes compared to the water extract [17]. In turn, 
the performed studies with the use of other cell lines, such 
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as MOLT-4F (IC50; 14.29 µg/mL), PC-3, HCT-15, SW-620, 
ACHN and A549 have showed the similar cytotoxic activity 
of extracts for all cell lines. The obtained IC50 values were 
on the level nearly 30 µg/mL. The extracts of the E. sessili-
florus seedlings have cytotoxic action towards Calu-6 and 
SMU-601 cell lines. The IC50 values were 25 µg/mL and 
196.7 µg/mL, respectively [2, 19, 6]. Other studies showed 
that the water extract from the stem bark of A. senticosus 
induced apoptosis in human stomach cancer KATO III cells 
[4]. Unfortunately, there is still little information on the anti-
leukemic activity of the other investigated species growing 
in Asia. 
An important problem in the evaluation of the cytotoxic 
properties of extracts is to establish the way of their action. 
Based on the presented results, it has appeared that Eleu-
therococcus species cultivated in Poland possess cytotoxic 
properties and act via apoptosis process. The extract from 
the roots of E. divaricatus showed the highest mortality 
(IC50, 49 µg/mL). Significantly, large differences in IC50 
value between the roots and the leaves from E. divaricatus 
and E. setchuensis have been observed. During apoptosis, 
the morphological features of cells such as compaction and 
margination of nuclear chromatin, cytoplasmic condensation 
and membrane blebbing and cell shrinkage were observed. 
Taking into account the results of own studies, it appears that 
some species from the Polish origin have stronger cytotoxic 
activity than those from Asia.
The most of the studied species have a significant biologi-
cal activity that is probably due to the presence of phenols, 
called as eleutherosides. To the best of our knowledge, 
neither phytochemical nor biological detailed studies have 
been performed for a majority of the investigated species. 
According to Załuski et al. these compounds are present only 
in the roots and fruits. Using a validated HPTLC-densito-
metric method, it appeared that the roots of the investigated 
species have high eleutherosides content [1, 16, 18]. The 
amount of eleutheroside B ranged between 0.5 mg/g and 3.4 
mg/g; eleutheroside E between 0.5 mg/g and 1.2 mg/g; and 
eleutheroside E1 between 0.2 and 0.9 mg/g of the sample, 
dry weight. The highest concentration of eleutherosides B 
and E was detected in E. henryi (3.4 mg/g and 1.2 mg/g, 
respectively), and of eleutheroside E1 in E. divaricatus (0.9 
mg/g). According to statistical analysis, positive correlation 
between cytotoxic activity and eleutherosides content was 
not found, which could be the result of the assay conditions 
or the chemical structure of the eleutherosides.
These first comprehensive studies during the apopto-
sis process have been researched with use of the eighteen 
extracts from six Eleutherococcus species. There is still great 
interest in finding more effective and safe cancer process 
inhibitors, so these plants are very promising source of bio-
logically active substances. Based on the obtained results 
and discussion, we can say that E. senticosus cultivated in 
Polish climatic conditions possesses strong pharmacologi-
cal properties in in vitro model. To develop our research, it 
is necessary to isolate and identify the active compounds.
CONCLUSIONS 
All these comparative studies for different parts of Eleu-
therococcus brought useful information on their potential 
use. The roots of E. divaricatus contain phytochemicals with 
the cytotoxic activity against leukemia cells. In the further 
research, the main attention will be focused on the isolation 
of single compounds and their cytotoxic activity against 
leukemic cells and normal human lymphocytes. Keeping 
in mind their rich biological properties, consumption, espe-
cially of the fresh fruits or the roots of extract products can 
act protectively against leukemia.
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